Lung Cancer Biomarkers and Screening
NCT00301119 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 3606
Last updated 2026-05-08
Summary
RATIONALE: Screening tests that use biomarkers may help doctors find tumor cells early and plan effective treatment for lung cancer.
PURPOSE: This clinical trial is studying biomarkers in screening participants for lung cancer.
Conditions
Sponsors & Collaborators
- lead OTHER
Principal Investigators
-
James J. Tsay, MD, MSc · NYU Langone Health
Eligibility
- Min Age
- 50 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2000-05-31
- Primary Completion
- 2030-05-31
- Completion
- 2030-05-31
Countries
- United States
Study Locations
More Related Trials
-
DNA Analysis of Blood and Tissue from Patients with Lung Cancer
NCT00471978 ·Status: RECRUITING
-
Study of Tissue Samples From Patients With Non-Small Cell Lung Cancer
NCT01414595 ·Status: COMPLETED
-
Identification and Validation of Blood-Based Biomarkers for Early Detection of Asymptomatic Lung Cancer in High-Risk Heavy Smokers
NCT06816121 ·Status: RECRUITING
-
Non-Invasive Biomarkers For Early Detection Of Lung Cancers
NCT01580332 ·Status: COMPLETED
-
Chest Imaging, Breath, and Biomarkers in a Screening Trial
NCT01663155 ·Status: COMPLETED
-
Studying Tumor Tissue Samples From Patients With Early-Stage Non-Small Cell Lung Cancer
NCT01517971 ·Status: COMPLETED
-
Pilot Study of High Risk Lung Cancer Screening
NCT03683940 ·Status: COMPLETED ·Phase: NA
-
Early Detection of Lung Cancer
NCT03181256 ·Status: ACTIVE_NOT_RECRUITING
-
Biomarkers for Early Detection of Lung Cancer in Patients With Lung Cancer, Participants at High-Risk for Developing Lung Cancer, or Healthy Volunteers
NCT00899262 ·Status: UNKNOWN
-
A Study of Lung Cancer Screening in People With Unexplained Weight Loss
NCT06717334 ·Status: RECRUITING
-
Development of a Biologic Specimen Bank for the Study of Early Markers of Lung Cancer Among Tin Miners in Yunnan, China
NCT00340405 ·Status: COMPLETED
-
Using Urine Samples to Identify Lung Cancer
NCT06033248 ·Status: RECRUITING
-
Circulating Tumor Cells (CTCs) as a Blood-based Tumor Marker in Patients With Small Cell Lung Cancer (SCLC)
NCT01173458 ·Status: COMPLETED
-
Liquid Biopsy for Early Non-small Lung Cancer Detection
NCT05462795 ·Status: COMPLETED
-
Molecular Markers in Predicting Lung Cancer Development Using Tissue Samples From Healthy Participants
NCT00899457 ·Status: COMPLETED
-
Enhancing Lung Cancer Screening Through Human-Centered Intervention
NCT06351085 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Biomarker Discovery and Validation in Lung Cancer
NCT01147562 ·Status: UNKNOWN ·Phase: NA
-
Chromosomal Instability as a Surrogate Biomarker of Drug Resistance in Immunotherapy for Lung Cancer Patients
NCT04203095 ·Status: UNKNOWN
-
Blood Sample Collection in Subjects With Pulmonary Nodules or CT Suspicion of Lung Cancer or Pathologically Diagnosed Lung Cancer
NCT03633006 ·Status: COMPLETED
-
Biomarkers for Risk Stratification in Lung Cancer
NCT03774758 ·Status: RECRUITING
-
Computed Tomography for Early Detection of Cancer in Women Who Are at Risk for Lung Cancer
NCT00012103 ·Status: COMPLETED ·Phase: NA
-
S0424 - Carcinogens in Lung Tissue From Smokers (Closed to Entry as of 7/15/07) and Non-Smokers With Newly Diagnosed Stage I, Stage II, or Stage III Non-Small Cell Lung Cancer
NCT00450281 ·Status: COMPLETED
-
Detection of Genetic Markers of Lung Cancer
NCT00280202 ·Status: RECRUITING
-
Biomarkers for Diagnosis of Lung Cancer
NCT02050100 ·Status: COMPLETED
-
Liquid Biopsy in Lung Cancer
NCT03479099 ·Status: COMPLETED